Oral contraceptive labeling
This article was originally published in The Tan Sheet
Executive Summary
FDA approves labeling changes recommended by FDA's Fertility & Maternal Health Advisory Committee that the physical examination "may be deferred until after initiation of oral contraceptives if requested by the woman and judged appropriate by the clinician." Requiring a physical exam prior to obtaining an OC prescription has long been an obstacle to switching the products to over-the- counter status, an idea that is still being considered by FDA ("The Tan Sheet" May 24, p. 5).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning